Literature DB >> 15248152

Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome.

Marco Tartaglia1, Viviana Cordeddu, Hong Chang, Adam Shaw, Kamini Kalidas, Andrew Crosby, Michael A Patton, Mariella Sorcini, Ineke van der Burgt, Steve Jeffery, Bruce D Gelb.   

Abstract

Germline mutations in PTPN11--the gene encoding the nonreceptor protein tyrosine phosphatase SHP-2--represent a major cause of Noonan syndrome (NS), a developmental disorder characterized by short stature and facial dysmorphism, as well as skeletal, hematologic, and congenital heart defects. Like many autosomal dominant disorders, a significant percentage of NS cases appear to arise from de novo mutations. Here, we investigated the parental origin of de novo PTPN11 lesions and explored the effect of paternal age in NS. By analyzing intronic portions that flank the exonic PTPN11 lesions in 49 sporadic NS cases, we traced the parental origin of mutations in 14 families. Our results showed that all mutations were inherited from the father, despite the fact that no substitution affected a CpG dinucleotide. We also report that advanced paternal age was observed among cohorts of sporadic NS cases with and without PTPN11 mutations and that a significant sex-ratio bias favoring transmission to males was present in subjects with sporadic NS caused by PTPN11 mutations, as well as in families inheriting the disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15248152      PMCID: PMC1182027          DOI: 10.1086/423493

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

1.  MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin.

Authors:  R Trappe; F Laccone; J Cobilanschi; M Meins; P Huppke; F Hanefeld; W Engel
Journal:  Am J Hum Genet       Date:  2001-04-17       Impact factor: 11.025

2.  PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome.

Authors:  Kenjiro Kosaki; Taichi Suzuki; Koji Muroya; Tomonobu Hasegawa; Seiji Sato; Nobutake Matsuo; Rika Kosaki; Toshiro Nagai; Yukihiro Hasegawa; Tsutomu Ogata
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

3.  Germline origins in the human F9 gene: frequent G:C-->A:T mosaicism and increased mutations with advanced maternal age.

Authors:  R P Ketterling; E Vielhaber; X Li; J Drost; D J Schaid; C K Kasper; J A Phillips; M A Koerper; H Kim; C Sexauer; R Gruppo; R Ambriz; R Paredes; S S Sommer
Journal:  Hum Genet       Date:  1999-12       Impact factor: 4.132

4.  PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.

Authors:  Marco Tartaglia; Kamini Kalidas; Adam Shaw; Xiaoling Song; Dan L Musat; Ineke van der Burgt; Han G Brunner; Débora R Bertola; Andrew Crosby; Andra Ion; Raju S Kucherlapati; Steve Jeffery; Michael A Patton; Bruce D Gelb
Journal:  Am J Hum Genet       Date:  2002-05-01       Impact factor: 11.025

5.  Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome.

Authors:  R L Glaser; W Jiang; S A Boyadjiev; A K Tran; A A Zachary; L Van Maldergem; D Johnson; S Walsh; M Oldridge; S A Wall; A O Wilkie; E W Jabs
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

6.  The parental origin of new mutations in neurofibromatosis 2.

Authors:  L Kluwe; V Mautner; D M Parry; L B Jacoby; M Baser; J Gusella; K Davis; D Stavrou; M MacCollin
Journal:  Neurogenetics       Date:  2000-09       Impact factor: 2.660

7.  Unexpectedly similar rates of nucleotide substitution found in male and female hominids.

Authors:  H B Bohossian; H Skaletsky; D C Page
Journal:  Nature       Date:  2000-08-10       Impact factor: 49.962

8.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Authors:  M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

9.  PTPN11 mutations in LEOPARD syndrome.

Authors:  E Legius; C Schrander-Stumpel; E Schollen; C Pulles-Heintzberger; M Gewillig; J-P Fryns
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

10.  Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.

Authors:  Maria Cristina Digilio; Emanuela Conti; Anna Sarkozy; Rita Mingarelli; Tania Dottorini; Bruno Marino; Antonio Pizzuti; Bruno Dallapiccola
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

View more
  21 in total

1.  Role of genomics in cardiovascular medicine.

Authors:  Giuseppe Novelli; Irene M Predazzi; Ruggiero Mango; Francesco Romeo; Jawahar L Mehta
Journal:  World J Cardiol       Date:  2010-12-26

Review 2.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

3.  Advancing age has differential effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies in sperm.

Authors:  A J Wyrobek; B Eskenazi; S Young; N Arnheim; I Tiemann-Boege; E W Jabs; R L Glaser; F S Pearson; D Evenson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

Review 4.  Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease.

Authors:  Anne Goriely; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2012-02-10       Impact factor: 11.025

5.  Are ECG abnormalities in Noonan syndrome characteristic for the syndrome?

Authors:  R Raaijmakers; C Noordam; J A Noonan; E A Croonen; C J A M van der Burgt; J M T Draaisma
Journal:  Eur J Pediatr       Date:  2008-02-13       Impact factor: 3.183

6.  Age-dependent germline mosaicism of the most common noonan syndrome mutation shows the signature of germline selection.

Authors:  Song-Ro Yoon; Soo-Kung Choi; Jordan Eboreime; Bruce D Gelb; Peter Calabrese; Norman Arnheim
Journal:  Am J Hum Genet       Date:  2013-05-30       Impact factor: 11.025

7.  Mutation Spectrum and Phenotypic Features in Noonan Syndrome with PTPN11 Mutations: Definition of Two Novel Mutations.

Authors:  Tahir Atik; Ayca Aykut; Filiz Hazan; Huseyin Onay; Damla Goksen; Sukran Darcan; Ajlan Tukun; Ferda Ozkinay
Journal:  Indian J Pediatr       Date:  2016-01-28       Impact factor: 1.967

8.  De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features.

Authors:  Oddmund Søvik; Suzanne Schubbert; Gunnar Houge; Solrun J Steine; Gunnar Norgård; Bernt Engelsen; Pål R Njølstad; Kevin Shannon; Anders Molven
Journal:  J Med Genet       Date:  2007-07       Impact factor: 6.318

Review 9.  Germline Stem Cell Competition, Mutation Hot Spots, Genetic Disorders, and Older Fathers.

Authors:  Norman Arnheim; Peter Calabrese
Journal:  Annu Rev Genomics Hum Genet       Date:  2016-04-08       Impact factor: 8.929

10.  Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors.

Authors:  Anne Goriely; Ruth M S Hansen; Indira B Taylor; Inge A Olesen; Grete Krag Jacobsen; Simon J McGowan; Susanne P Pfeifer; Gilean A T McVean; Ewa Rajpert-De Meyts; Andrew O M Wilkie
Journal:  Nat Genet       Date:  2009-10-25       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.